CERNA2 and metastatic malignant neoplasm in the lymph nodes: As the outcomes displayed in Fig. 1b-d, the expression of HOST2 was notably higher in TNBC patients with advanced stage (Fig. 1b), lymph node metastasis (Fig. 1c) and distant metastasis (Fig. 1d).